Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified?

Rev Esp Cardiol (Engl Ed). 2021 Oct;74(10):891-893. doi: 10.1016/j.rec.2021.05.001. Epub 2021 Jun 2.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Coronary Syndrome*
  • Humans
  • Risk Factors